BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trpkov K, Hes O. New and emerging renal entities: a perspective post-WHO 2016 classification. Histopathology 2019;74:31-59. [DOI: 10.1111/his.13727] [Cited by in Crossref: 43] [Cited by in F6Publishing: 53] [Article Influence: 10.8] [Reference Citation Analysis]
Number Citing Articles
1 Amin MB, McKenney JK, Martignoni G, Campbell SC, Pal S, Tickoo SK. Low grade oncocytic tumors of the kidney: a clinically relevant approach for the workup and accurate diagnosis. Mod Pathol 2022. [PMID: 35896615 DOI: 10.1038/s41379-022-01108-5] [Reference Citation Analysis]
2 Moch H, Amin MB, Berney DM, Compérat EM, Gill AJ, Hartmann A, Menon S, Raspollini MR, Rubin MA, Srigley JR, Hoon Tan P, Tickoo SK, Tsuzuki T, Turajlic S, Cree I, Netto GJ. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol 2022:S0302-2838(22)02467-8. [PMID: 35853783 DOI: 10.1016/j.eururo.2022.06.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
3 Gonçalves JPL, Bollwein C, Schwamborn K. Mass Spectrometry Imaging Spatial Tissue Analysis toward Personalized Medicine. Life (Basel) 2022;12:1037. [PMID: 35888125 DOI: 10.3390/life12071037] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Angori S, Lobo J, Moch H. Papillary renal cell carcinoma: current and controversial issues. Curr Opin Urol 2022;32:344-51. [PMID: 35674688 DOI: 10.1097/MOU.0000000000001000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhang J, Dong A, Wang Y. FDG PET/CT in Eosinophilic Solid and Cystic Renal Cell Carcinoma With Lung Metastases. Clin Nucl Med 2022. [PMID: 35605053 DOI: 10.1097/RLU.0000000000004282] [Reference Citation Analysis]
6 Paner GP, Chumbalkar V, Montironi R, Moch H, Amin MB. Updates in Grading of Renal Cell Carcinomas Beyond Clear Cell Renal Cell Carcinoma and Papillary Renal Cell Carcinoma. Adv Anat Pathol 2022;29:117-30. [PMID: 35275846 DOI: 10.1097/PAP.0000000000000341] [Reference Citation Analysis]
7 Tomaszewski Z, Littler Y. Unclassified Oncocytic Renal Neoplasm with Rib and Liver Metastases: Metastatic Oncocytoma? Int J Surg Pathol 2022;:10668969221084265. [PMID: 35274993 DOI: 10.1177/10668969221084265] [Reference Citation Analysis]
8 Hes O, Trpkov K. Do we need an updated classification of oncocytic renal tumors? : Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities. Mod Pathol 2022. [PMID: 35273336 DOI: 10.1038/s41379-022-01057-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Gopee-Ramanan P, Chin SS, Lim C, Shanbhogue KP, Schieda N, Krishna S. Renal Neoplasms in Young Adults. Radiographics 2022;42:433-50. [PMID: 35230920 DOI: 10.1148/rg.210138] [Reference Citation Analysis]
10 Zhang H, Xia Q, Wang S, Shi M, Wang S. Low-grade oncocytic tumor of kidney harboring TSC/MTOR mutation: clinicopathologic, immunohistochemical and molecular characteristics support a distinct entity. Virchows Arch. [DOI: 10.1007/s00428-022-03283-x] [Reference Citation Analysis]
11 Pivovarcikova K, Alaghehbandan R, Vanecek T, Ohashi R, Pitra T, Hes O. TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background. Biomedicines 2022;10:322. [DOI: 10.3390/biomedicines10020322] [Reference Citation Analysis]
12 Akgul M, Williamson SR. Immunohistochemistry for the diagnosis of renal epithelial neoplasms. Semin Diagn Pathol 2022;39:1-16. [PMID: 34823973 DOI: 10.1053/j.semdp.2021.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Mohanty SK, Satapathy A, Aggarwal A, Mishra SK, Sampat NY, Sharma S, Williamson SR. Oncocytic renal neoplasms with diffuse keratin 7 immunohistochemistry harbor frequent alterations in the mammalian target of rapamycin pathway. Mod Pathol 2021. [PMID: 34802045 DOI: 10.1038/s41379-021-00969-6] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
14 Sakhadeo U, Yadav SC, Bakshi GK, Prakash G, Katdare A, Menon S, Desai SB. Eosinophilic solid cystic renal cell carcinoma: A series of 3 cases elucidating the spectrum of morphological and clinical features of an emerging new entity. Indian J Urol 2021;37:350-4. [PMID: 34759528 DOI: 10.4103/iju.iju_217_21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Çoban G, Yildiz P, Doğan B, Şahin N, Gücin Z. Expression of transient receptor potential melastatin 4 in differential diagnosis of eosinophilic renal tumors. Mol Clin Oncol 2021;15:230. [PMID: 34631055 DOI: 10.3892/mco.2021.2393] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Lobo J, Ohashi R, Helmchen BM, Rupp NJ, Rüschoff JH, Moch H. The Morphological Spectrum of Papillary Renal Cell Carcinoma and Prevalence of Provisional/Emerging Renal Tumor Entities with Papillary Growth. Biomedicines 2021;9:1418. [PMID: 34680535 DOI: 10.3390/biomedicines9101418] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
17 Kapur P, Gao M, Zhong H, Chintalapati S, Mitui M, Barnes SD, Zhou Q, Miyata J, Carrillo D, Malladi VS, Rakheja D, Pedrosa I, Xu L, Kinch L, Brugarolas J. Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney. Mod Pathol 2021. [PMID: 34538873 DOI: 10.1038/s41379-021-00896-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zyla RE, Hodgson A. Gene of the month: FH. J Clin Pathol 2021:jclinpath-2021-207830. [PMID: 34353877 DOI: 10.1136/jclinpath-2021-207830] [Reference Citation Analysis]
19 Pontes O, Oliveira-Pinto S, Baltazar F, Costa M. Renal cell carcinoma therapy: Current and new drug candidates. Drug Discov Today 2021:S1359-6446(21)00313-5. [PMID: 34265458 DOI: 10.1016/j.drudis.2021.07.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
20 Karatay H, Ozluk Y, Dogan MA, Erdem S, Kilicaslan I. Immunoexpression of SDHB, FH, and CK20 among eosinophilic renal tumors: A tissue microarray study. Ann Diagn Pathol 2021;54:151788. [PMID: 34246177 DOI: 10.1016/j.anndiagpath.2021.151788] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Baniak N, Barletta JA, Hirsch MS. Key Renal Neoplasms With a Female Predominance. Adv Anat Pathol 2021;28:228-50. [PMID: 34009777 DOI: 10.1097/PAP.0000000000000301] [Reference Citation Analysis]
22 Akgul M, Al-Obaidy KI, Cheng L, Idrees MT. Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: a review of 23 cases from a single tertiary institute. J Clin Pathol 2021:jclinpath-2021-207478. [PMID: 34168073 DOI: 10.1136/jclinpath-2021-207478] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
23 Lerma LA, Schade GR, Tretiakova MS. Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia but without clinical features of tuberous sclerosis complex. Hum Pathol 2021;116:1-11. [PMID: 34153307 DOI: 10.1016/j.humpath.2021.06.002] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
24 Cabanillas G, Montoya-Cerrillo D, Kryvenko ON, Pal SK, Arias-Stella JA 3rd. "Collecting duct carcinoma of the kidney: diagnosis and implications for management". Urol Oncol 2021:S1078-1439(21)00204-0. [PMID: 34116936 DOI: 10.1016/j.urolonc.2021.04.041] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Al-Obaidy KI, Bridge JA, Cheng L, Sumegi J, Reuter VE, Benayed R, Hameed M, Williamson SR, Hes O, Alruwaii FI, Segal JP, Wanjari P, Idrees MT, Nassiri M, Eble JN, Grignon DJ. EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma. Mod Pathol 2021. [PMID: 34099871 DOI: 10.1038/s41379-021-00833-7] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
26 Kwon R, Argani P, Epstein JI, Lombardo KA, Wang X, Pierorazio PM, Mehra R, Matoso A. Contemporary Characterization and Recategorization of Adult Unclassified Renal Cell Carcinoma. Am J Surg Pathol 2021;45:450-62. [PMID: 33239504 DOI: 10.1097/PAS.0000000000001629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Barthélémy P, Rioux-Leclercq N, Thibault C, Saldana C, Borchiellini D, Chevreau C, Desmoulins I, Gobert A, Hilgers W, Khalil A, Lemoine N, Schlürmann-Constans F, Négrier S. Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data. Cancer Treat Rev 2021;97:102191. [PMID: 34015728 DOI: 10.1016/j.ctrv.2021.102191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Pivovarcikova K, Grossmann P, Hajkova V, Alaghehbandan R, Pitra T, Perez Montiel D, Sperga M, Rogala J, Slisarenko M, Bartos Vesela A, Svajdler P, Michalova K, Rotterova P, Hora M, Michal M, Hes O. Renal cell carcinomas with tubulopapillary architecture and oncocytic cells: Molecular analysis of 39 difficult tumors to classify. Ann Diagn Pathol 2021;52:151734. [PMID: 33838490 DOI: 10.1016/j.anndiagpath.2021.151734] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Jian Y, Yang K, Sun X, Zhao J, Huang K, Aldanakh A, Xu Z, Wu H, Xu Q, Zhang L, Xu C, Yang D, Wang S. Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma. Front Immunol 2021;12:639636. [PMID: 33767709 DOI: 10.3389/fimmu.2021.639636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
30 Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Gill AJ. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol 2021;34:1392-424. [PMID: 33664427 DOI: 10.1038/s41379-021-00779-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 49] [Article Influence: 7.0] [Reference Citation Analysis]
31 Ishikawa N, Kimura N, Yoshida T, Yoshimura I, Nakahara K, Tsuzuki T, Tokunaga O. A Case of Low-Grade Oncocytic Tumor/Chromophobe Renal Cell Carcinoma (Oncocytic Variant) of the Kidney. Case Rep Pathol 2021;2021:6684777. [PMID: 33680526 DOI: 10.1155/2021/6684777] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
32 Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen Y, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-galluzzi C, Mckenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Hes O. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol 2021;34:1167-84. [DOI: 10.1038/s41379-021-00737-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
33 Athanazio DA, Amorim LS, da Cunha IW, Leite KRM, da Paz AR, de Paula Xavier Gomes R, Tavora FRF, Faraj SF, Cavalcanti MS, Bezerra SM. Classification of renal cell tumors – current concepts and use of ancillary tests: recommendations of the Brazilian Society of Pathology. Surg Exp Pathol 2021;4. [DOI: 10.1186/s42047-020-00084-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Akgul M, Saeed O, Levy D, Mann SA, Cheng L, Grignon DJ, Eble JN, Idrees MT. Morphologic and Immunohistochemical Characteristics of Fluorescent In Situ Hybridization Confirmed TFE3-Gene Fusion Associated Renal Cell Carcinoma: A Single Institutional Cohort. Am J Surg Pathol 2020;44:1450-8. [PMID: 32701515 DOI: 10.1097/PAS.0000000000001541] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
35 de Andrade Melo CGR, Xavier MVN, Pimenta IS, Athanazio DA. Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive). Surg Exp Pathol 2020;3. [DOI: 10.1186/s42047-020-00074-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Guo Q, Liu N, Wang F, Guo Y, Yang B, Cao Z, Wang Y, Wang Y, Zhang W, Huang Q, Zhao W, Liu C, Qu T, Li L, Cao L, Ren D, Meng B, Qi L, Wang C, Cao W. Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China. Virchows Arch 2021;478:449-58. [PMID: 32918598 DOI: 10.1007/s00428-020-02927-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
37 Zhang X, Tretiakova M. Biphasic Squamoid Alveolar Renal Cell Carcinoma of the Kidney Involved by Atypical CD5-Positive B-Cells. Int J Surg Pathol 2021;29:427-32. [PMID: 32909465 DOI: 10.1177/1066896920957089] [Reference Citation Analysis]
38 Tretiakova MS. Renal Cell Tumors: Molecular Findings Reshaping Clinico-pathological Practice. Arch Med Res 2020;51:799-816. [PMID: 32839003 DOI: 10.1016/j.arcmed.2020.08.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
39 Yang C, Shuch B, Kluger H, Humphrey PA, Adeniran AJ. High WHO/ISUP Grade and Unfavorable Architecture, Rather Than Typing of Papillary Renal Cell Carcinoma, May Be Associated With Worse Prognosis. Am J Surg Pathol 2020;44:582-93. [PMID: 32101890 DOI: 10.1097/PAS.0000000000001455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
40 Shah RB, Stohr BA, Tu ZJ, Gao Y, Przybycin CG, Nguyen J, Cox RM, Rashid-Kolvear F, Weindel MD, Farkas DH, Trpkov K, McKenney JK. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity. Am J Surg Pathol 2020;44:571-81. [PMID: 31850909 DOI: 10.1097/PAS.0000000000001422] [Cited by in Crossref: 12] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
41 Liu YJ, Ussakli C, Antic T, Liu Y, Wu Y, True L, Tretiakova MS. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling. Hum Pathol 2020;104:18-29. [PMID: 32673684 DOI: 10.1016/j.humpath.2020.07.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
42 Cimadamore A, Aurilio G, Nolé F, Massari F, Scarpelli M, Santoni M, Lopez-Beltran A, Cheng L, Montironi R. Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer. Cells 2020;9:E1495. [PMID: 32575429 DOI: 10.3390/cells9061495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
43 Williamson SR, Cardili L, Whiteley LJ, Sanchez J, Kis O. Sclerosing TSC1 mutated renal cell carcinoma: An unusual pattern mimicking MITF family translocation renal cell carcinoma. Genes Chromosomes Cancer 2020;59:591-4. [PMID: 32418252 DOI: 10.1002/gcc.22860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
44 Woo CG, Yun SJ, Son SM, Lim YH, Lee OJ. Characteristics of Renal Cell Carcinoma Harboring TPM3-ALK Fusion. Yonsei Med J 2020;61:262-6. [PMID: 32102128 DOI: 10.3349/ymj.2020.61.3.262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
45 Osmanov YI, Kogan EA, Radenska-Lopovok SG. [The morphological characteristics and immunophenotype of renal cell carcinomas with eosinophilic cytoplasm]. Arkh Patol 2020;82:20-9. [PMID: 32307435 DOI: 10.17116/patol20208202120] [Reference Citation Analysis]
46 Rupp NJ, Moch H. [Characterization of different renal cell carcinoma entities]. Urologe A 2020;59:135-41. [PMID: 31974661 DOI: 10.1007/s00120-019-01108-5] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Manini C, López JI. The Labyrinth of Renal Cell Carcinoma. Cancers (Basel) 2020;12:E521. [PMID: 32102400 DOI: 10.3390/cancers12020521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
48 Siadat F, Trpkov K. ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification. Cancers (Basel) 2020;12:E168. [PMID: 31936678 DOI: 10.3390/cancers12010168] [Cited by in Crossref: 16] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
49 Trpkov K, Siadat F. Immunohistochemical screening for the diagnosis of succinate dehydrogenase-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma. Ann Transl Med 2019;7:S324. [PMID: 32016042 DOI: 10.21037/atm.2019.09.143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
50 Lau HD, Chan E, Fan AC, Kunder CA, Williamson SR, Zhou M, Idrees MT, Maclean FM, Gill AJ, Kao C. A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients. American Journal of Surgical Pathology 2020;44:98-110. [DOI: 10.1097/pas.0000000000001372] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
51 Cimadamore A, Massari F, Santoni M, Mollica V, Di Nunno V, Cheng L, Lopez-Beltran A, Scarpelli M, Montironi R, Moch H. Molecular characterization and diagnostic criteria of renal cell carcinoma with emphasis on liquid biopsies. Expert Rev Mol Diagn 2020;20:141-50. [PMID: 31498685 DOI: 10.1080/14737159.2019.1665510] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
52 Tretiakova MS, Kehr EL, Gore JL, Tykodi SS. Thyroid-Like Follicular Renal Cell Carcinoma Arising Within Benign Mixed Epithelial and Stromal Tumor. Int J Surg Pathol 2020;28:80-6. [PMID: 31342803 DOI: 10.1177/1066896919863478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
53 Trpkov K, Williamson SR, Gao Y, Martinek P, Cheng L, Sangoi AR, Yilmaz A, Wang C, San Miguel Fraile P, Perez Montiel DM, Bulimbasić S, Rogala J, Hes O. Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity? Histopathology 2019;75:174-84. [PMID: 30895640 DOI: 10.1111/his.13865] [Cited by in Crossref: 30] [Cited by in F6Publishing: 52] [Article Influence: 10.0] [Reference Citation Analysis]